Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Trump signs order to hasten psychedelic medicine access

 April 19, 2026

Pharmaphorum

Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of bringing psychedelics to patients.

Policy / PricingNeuroscienceRead full story

Post navigation

Kailera makes history with record-breaking $625m IPO →
← What actually drives speed in complex drug development programs

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com